학술논문
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START).
Document Type
Article
Author
Poli, Daniela; Ageno, Walter; Antonucci, Emilia; Bradamante, Salvatore; Bucherini, Eugenio; Chiarugi, Paolo; Chistolini, Antonio; Cosmi, Benilde; Falanga, Anna; Insana, Antonio; Lione, Domenico; Maria Lombardi, Rosa; Malcangi, Giuseppe; Marcucci, Rossella; Martini, Giuliana; Masciocco, Lucilla; Paparo, Carmelo; Pastori, Daniele; Pedrini, Simona; Pengo, Vittorio
Source
Subject
*ATRIAL fibrillation
*ANTICOAGULANTS
*ORAL medication
*
*
Language
ISSN
2785-5309
Abstract
The survey on anticoagulated patients register (START-Register) is an independent, prospective, inception-cohort observational study aimed at providing information on patients on vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) in Italy. In this study, we describe the cohort of atrial fibrillation (AF) patients in the START-Register and report outcomes and changes in anticoagulant prescription from 2011 to 2021. The study included 11,078 AF patients, enrolled in 47 Italian centers distributed all over the Country; the median age was 77 years (range 18-99 years); 6,029 (54.3%) were men; 5,135 (46.4%) were on VKAs, and 5,943 (53.6%) were on DOACs. Warfarin was the most prescribed VKA (98.4%), and apixaban was the most prescribed DOAC (31.6%). Among DOAC users, 4,022 (67.7%) patients were naive to anticoagulation, and 2,562 (43.1%) patients were treated with a reduced dose. DOAC patients were significantly older than VKA patients (median age 79 years vs 76 years respectively, P<0.001), but no gender difference was detected. The mean CHA2DS2VASc score was higher in DOAC users than in VKA users (3.7 vs 3.6; P=0.03). The mean HAS-BLED score was not different between the two groups. During follow-up, 542 bleeding events were recorded [2.44 per 100 patient-years (pt-yrs)]; 240 were major (1.08 per 100 pt-yrs), and 301 were clinically relevant nonmajor bleedings (1.34 per 100 pt-yrs). 146 thrombotic events were recorded during follow-up (0.66 per 100 pt-yrs). The total mortality rate was 3.5 per 100 pt-yrs; the mortality rate was 4.54 per 100 pt-yrs among patients on VKAs and 2.31 per 100 pt-yrs among patients on DOACs. During the last 10 years, in Italy, AF patient management has changed with the large spread of DOACs all over the Country. DOAC patients are frequently treated with reduced doses and show a lower mortality rate in comparison to patients on VKAs. [ABSTRACT FROM AUTHOR]